Clinical Trial Update: Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Sanofi reports that the Phase 2 trial of SAR444656 in adults with moderate to severe atopic dermatitis has been terminated. The update notes the study status as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• SAR444656

Snippet

Sponsor: Sanofi | Conditions: Atopic Dermatitis | Phase 2 | Status: TERMINATED